1. A cholecystokinin receptor antagonist inhibits the osteoarthritis features induced by GPR22 in vitro and in vivo. (April 2018) Authors: Guns, L.; Monteagudo, S.; Calebiro, D.; Lohse, M.; Lories, R.; Cailotto, F. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A cholecystokinin receptor antagonist inhibits chondrocyte hypertrophy and protein kinase a activity decrease induced by activation of GPR22. (April 2016) Authors: Guns, L.-A.K.; Calebiro, D.; Lohse, M.J.; Lories, R.; Cailotto, F. Journal: Osteoarthritis and cartilage Issue: Volume 24(2016)Supplement 1 Page Start: S178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗